Completed Phase 3 enrollment for DURAVYU™ in wet AMD with over 800 patients enrolled and randomized – – LUGANO and LUCIA ...

The eye of the apple snail is unusually similar to a human eye—but, unlike human eyes, it can regrow itself if injured ...

Ocugen says it is on track to reshape the market for gene therapies against eye disorders over the next three years, by ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.

CARLSBAD, CA, USA I August 04, 2025 I Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel ...

Pavblu, an Eylea HD biosimilar, shows stable vision outcomes and minimal side effects in real-world use, promising a reliable ...

Investigators defined an IOP spike as >40 mm Hg or an increase ≥10 mm Hg after injection. The population was older (mean age ...

Ophthalmologists are a critical part of the medical team needed to treat thyroid eye disease.An endocrinologist is usually the team leader, but ophthalmologists, diagnostic and therapeutic ...

While the broader stock market suffered steep losses amid trade policy shifts select health technology equities stood out.

Basel: Roche has announced new, five-year efficacy, safety and durability data from the Phase III Portal study, a long-term ...